[HTML][HTML] Targeting ubiquitin-like protein, isg15, as a novel tumor associated antigen in colorectal cancer
Simple Summary Despite their potential and promising anti-tumor efficacy, previously
developed cancer vaccines targeting different tumor-associated antigens for colorectal …
developed cancer vaccines targeting different tumor-associated antigens for colorectal …
Targeting Ubiquitin-like Protein, ISG15, as a Novel Tumor Associated Antigen in Colorectal Cancer
HM Nguyen, S Gaikwad, M Oladejo… - …, 2023 - pubmed.ncbi.nlm.nih.gov
Colorectal cancer (CRC) is the third leading cause of cancer-related deaths in both men and
women in the United States. While immune checkpoint inhibitor (ICI) therapy is …
women in the United States. While immune checkpoint inhibitor (ICI) therapy is …
Targeting Ubiquitin-like Protein, ISG15, as a Novel Tumor Associated Antigen in Colorectal Cancer.
HM Nguyen, S Gaikwad, M Oladejo, W Paulishak… - …, 2023 - search.ebscohost.com
Abstract Simple Summary: Despite their potential and promising anti-tumor efficacy,
previously developed cancer vaccines targeting different tumor-associated antigens for …
previously developed cancer vaccines targeting different tumor-associated antigens for …
[HTML][HTML] Targeting Ubiquitin-like Protein, ISG15, as a Novel Tumor Associated Antigen in Colorectal Cancer
HM Nguyen, S Gaikwad, M Oladejo, W Paulishak… - mdpi.com
Background: Tumor mutational burden (TMB) and stromal CD8-positive tumor-infiltrating
lymphocytes (CD8+ TILs) serve important roles in antitumor immune responses to …
lymphocytes (CD8+ TILs) serve important roles in antitumor immune responses to …
Targeting Ubiquitin-like Protein, ISG15, as a Novel Tumor Associated Antigen in Colorectal Cancer
HM Nguyen, S Gaikwad, M Oladejo, W Paulishak… - …, 2023 - search.proquest.com
Colorectal cancer (CRC) is the third leading cause of cancer-related deaths in both men and
women in the United States. While immune checkpoint inhibitor (ICI) therapy is …
women in the United States. While immune checkpoint inhibitor (ICI) therapy is …
[HTML][HTML] Targeting Ubiquitin-like Protein, ISG15, as a Novel Tumor Associated Antigen in Colorectal Cancer
HM Nguyen, S Gaikwad, M Oladejo, W Paulishak… - Cancers, 2023 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) is the third leading cause of cancer-related deaths in both men and
women in the United States. While immune checkpoint inhibitor (ICI) therapy is …
women in the United States. While immune checkpoint inhibitor (ICI) therapy is …
Targeting Ubiquitin-like Protein, ISG15, as a Novel Tumor Associated Antigen in Colorectal Cancer.
HM Nguyen, S Gaikwad, M Oladejo, W Paulishak… - Cancers, 2023 - europepmc.org
Colorectal cancer (CRC) is the third leading cause of cancer-related deaths in both men and
women in the United States. While immune checkpoint inhibitor (ICI) therapy is …
women in the United States. While immune checkpoint inhibitor (ICI) therapy is …
[PDF][PDF] Targeting Ubiquitin-like Protein, ISG15, as a Novel Tumor Associated Antigen in Colorectal Cancer
HM Nguyen, S Gaikwad, M Oladejo… - …, 2014 - pdfs.semanticscholar.org
Colorectal cancer (CRC) is the third leading cause of cancer-related deaths in both men and
women in the United States. While immune checkpoint inhibitor (ICI) therapy is …
women in the United States. While immune checkpoint inhibitor (ICI) therapy is …
[引用][C] Targeting Ubiquitin-like Protein, ISG15, as a Novel Tumor Associated Antigen in Colorectal Cancer
HM Nguyen, S Gaikwad, M Oladejo, W Paulishak… - therapy, 2014 - europepmc.org
Colorectal cancer (CRC) is the third leading cause of cancer-related deaths in both men and
women in the United States. While immune checkpoint inhibitor (ICI) therapy is …
women in the United States. While immune checkpoint inhibitor (ICI) therapy is …